ARCHIVES

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Bill Planned To Okay Medicare/Medicaid Payment For 100% Of Outpatient Anticancer Drug Costs

February 16, 1979

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

NCI to Host SBIR Investor Forum

November 7, 2014

FDA Designates Zometa For Priority Review.

November 30, 2001

Garb Denies He, Panel Said Contract Should Be Primary Funding Mechanism

March 17, 1978

Panel Considers Easing Comp Center Independence Requirement, but Realizes It Lacks That Authority

February 18, 1977